Sertraline HCL Tablets
Award NoticeAwarded
This federal contract opportunity has been awarded to on June 28, 2021.
Award Information
This solicitation resulted in an award to for approximately $24,078,212 on June 28, 2021. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).
Award details updated on June 6, 2026 following modification notice.
- Award Number
- SPE2D221D0135
- Award Amount
- $24,078,212
- Award Date
- June 28, 2021
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Pharmaceutical Preparation Manufacturing
Contract Details
- Notice ID
- SPE2D220R0067
- Opportunity Type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Friday, June 13, 2025
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
